Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136125878> ?p ?o ?g. }
- W3136125878 endingPage "71" @default.
- W3136125878 startingPage "60" @default.
- W3136125878 abstract "Abstract Background Neutralizing antibodies (nAbs) against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) can play an important role in reducing impacts of the COVID-19 pandemic, complementing ongoing public health efforts such as diagnostics and vaccination. Rapidly designing, manufacturing and distributing nAbs requires significant planning across the product value chain and an understanding of the opportunities, challenges and risks throughout. Methods A systems framework comprised of four critical components is presented to aid in developing effective end-to-end nAbs strategies in the context of a pandemic: (1) product design and optimization, (2) epidemiology, (3) demand and (4) supply. Quantitative models are used to estimate product demand using available epidemiological data, simulate biomanufacturing operations from typical bioprocess parameters and calculate antibody production costs to meet clinical needs under various realistic scenarios. Results In a US-based case study during the 9-month period from March 15 to December 15, 2020, the projected number of SARS-CoV-2 infections was 15.73 million. The estimated product volume needed to meet therapeutic demand for the maximum number of clinically eligible patients ranged between 6.3 and 31.5 tons for 0.5 and 2.5 g dose sizes, respectively. The relative production scale and cost needed to meet demand are calculated for different centralized and distributed manufacturing scenarios. Conclusions Meeting demand for anti-SARS-CoV-2 nAbs requires significant manufacturing capacity and planning for appropriate administration in clinical settings. MIT Center for Biomedical Innovation’s data-driven tools presented can help inform time-critical decisions by providing insight into important operational and policy considerations for making nAbs broadly accessible, while considering time and resource constraints." @default.
- W3136125878 created "2021-03-29" @default.
- W3136125878 creator A5042953895 @default.
- W3136125878 creator A5060581747 @default.
- W3136125878 creator A5088944993 @default.
- W3136125878 date "2021-01-01" @default.
- W3136125878 modified "2023-09-25" @default.
- W3136125878 title "Models to inform neutralizing antibody therapy strategies during pandemics: the case of SARS-CoV-2" @default.
- W3136125878 cites W1963838989 @default.
- W3136125878 cites W1968895408 @default.
- W3136125878 cites W1982368369 @default.
- W3136125878 cites W2018033335 @default.
- W3136125878 cites W2034740932 @default.
- W3136125878 cites W2035070408 @default.
- W3136125878 cites W2073539776 @default.
- W3136125878 cites W2075009534 @default.
- W3136125878 cites W2085575701 @default.
- W3136125878 cites W2096238447 @default.
- W3136125878 cites W2118447105 @default.
- W3136125878 cites W2133701960 @default.
- W3136125878 cites W2134238361 @default.
- W3136125878 cites W2147401031 @default.
- W3136125878 cites W2159532401 @default.
- W3136125878 cites W2544612685 @default.
- W3136125878 cites W2727086257 @default.
- W3136125878 cites W2933635354 @default.
- W3136125878 cites W2948534853 @default.
- W3136125878 cites W2966471540 @default.
- W3136125878 cites W2986511818 @default.
- W3136125878 cites W2995755986 @default.
- W3136125878 cites W3012764845 @default.
- W3136125878 cites W3013967887 @default.
- W3136125878 cites W3016900702 @default.
- W3136125878 cites W3018043055 @default.
- W3136125878 cites W3023698680 @default.
- W3136125878 cites W3033249816 @default.
- W3136125878 cites W3034202401 @default.
- W3136125878 cites W3036356470 @default.
- W3136125878 cites W3036931136 @default.
- W3136125878 cites W3038804008 @default.
- W3136125878 cites W3042291772 @default.
- W3136125878 cites W3043815734 @default.
- W3136125878 cites W3044660350 @default.
- W3136125878 cites W3063924106 @default.
- W3136125878 cites W3080387602 @default.
- W3136125878 cites W3080610776 @default.
- W3136125878 cites W3082732146 @default.
- W3136125878 cites W3083773456 @default.
- W3136125878 cites W3088420451 @default.
- W3136125878 cites W3092301564 @default.
- W3136125878 cites W3092403777 @default.
- W3136125878 cites W3096064145 @default.
- W3136125878 cites W3096243826 @default.
- W3136125878 cites W3107915560 @default.
- W3136125878 cites W3113325024 @default.
- W3136125878 cites W3120714204 @default.
- W3136125878 cites W3121906900 @default.
- W3136125878 cites W3123733204 @default.
- W3136125878 cites W3125266951 @default.
- W3136125878 doi "https://doi.org/10.1093/abt/tbab006" @default.
- W3136125878 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8022923" @default.
- W3136125878 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33928236" @default.
- W3136125878 hasPublicationYear "2021" @default.
- W3136125878 type Work @default.
- W3136125878 sameAs 3136125878 @default.
- W3136125878 citedByCount "1" @default.
- W3136125878 countsByYear W31361258782021 @default.
- W3136125878 crossrefType "journal-article" @default.
- W3136125878 hasAuthorship W3136125878A5042953895 @default.
- W3136125878 hasAuthorship W3136125878A5060581747 @default.
- W3136125878 hasAuthorship W3136125878A5088944993 @default.
- W3136125878 hasBestOaLocation W31361258781 @default.
- W3136125878 hasConcept C108713360 @default.
- W3136125878 hasConcept C142724271 @default.
- W3136125878 hasConcept C144133560 @default.
- W3136125878 hasConcept C150903083 @default.
- W3136125878 hasConcept C162853370 @default.
- W3136125878 hasConcept C166957645 @default.
- W3136125878 hasConcept C205649164 @default.
- W3136125878 hasConcept C2524010 @default.
- W3136125878 hasConcept C2775893736 @default.
- W3136125878 hasConcept C2777691041 @default.
- W3136125878 hasConcept C2779134260 @default.
- W3136125878 hasConcept C2779343474 @default.
- W3136125878 hasConcept C3007834351 @default.
- W3136125878 hasConcept C3008058167 @default.
- W3136125878 hasConcept C33923547 @default.
- W3136125878 hasConcept C524204448 @default.
- W3136125878 hasConcept C71924100 @default.
- W3136125878 hasConcept C86803240 @default.
- W3136125878 hasConcept C89623803 @default.
- W3136125878 hasConcept C90673727 @default.
- W3136125878 hasConceptScore W3136125878C108713360 @default.
- W3136125878 hasConceptScore W3136125878C142724271 @default.
- W3136125878 hasConceptScore W3136125878C144133560 @default.
- W3136125878 hasConceptScore W3136125878C150903083 @default.
- W3136125878 hasConceptScore W3136125878C162853370 @default.
- W3136125878 hasConceptScore W3136125878C166957645 @default.